0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Alzheimer's Disease Diagnostic Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Published Date: September 2022
|
Report Code: QYRE-Auto-35E12001
Home | Market Reports | Health| Aging & Geriatrics
Global Alzheimer s Disease Diagnostic Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Global Alzheimer's Disease Diagnostic Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Code: QYRE-Auto-35E12001
Report
September 2022
Pages:99
QYResearch
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Alzheimer's disease (AD), also referred to simply asAlzheimer's, is a chronic neurodegenerative diseasethat usually starts slowly and worsens over time. It is the cause of 60–70% of cases of dementia. The most common early symptom is difficulty in remembering recent events (short-term memory loss).
Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Alzheimer's Disease Diagnostic estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.

The USA market for Alzheimer's Disease Diagnostic is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The China market for Alzheimer's Disease Diagnostic is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The Europe market for Alzheimer's Disease Diagnostic is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The global key companies of Alzheimer's Disease Diagnostic include Eli Lilly, TauRx, Alector, Accera, Treventis, Neuro-Bio and Cognition Therapeutics, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Alzheimer's Disease Diagnostic companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Alzheimer's Disease Diagnostic market. Further, it explains the major drivers and regional dynamics of the global Alzheimer's Disease Diagnostic market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Eli Lilly
TauRx
Alector
Accera
Treventis
Neuro-Bio
Cognition Therapeutics
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Alzheimer's Disease Diagnostic Segment by Type

Genetic Testing
Neurological Exam
Mini-Mental State Exam(MMSE)
Brain Imaging
Other

Alzheimer's Disease Diagnostic Segment by Application

Clinics
Hospitals
Diagnostic Centers
Other
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Alzheimer's Disease Diagnostic market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Alzheimer's Disease Diagnostic market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Alzheimer's Disease Diagnostic, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Alzheimer's Disease Diagnostic, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Alzheimer's Disease Diagnostic revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Alzheimer's Disease Diagnostic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Alzheimer's Disease Diagnostic revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Eli Lilly, TauRx, Alector, Accera, Treventis, Neuro-Bio and Cognition Therapeutics, etc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alzheimer's Disease Diagnostic Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Genetic Testing
1.2.3 Neurological Exam
1.2.4 Mini-Mental State Exam(MMSE)
1.2.5 Brain Imaging
1.2.6 Other
1.3 Market by Application
1.3.1 Global Alzheimer's Disease Diagnostic Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Diagnostic Centers
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Alzheimer's Disease Diagnostic Market Size (2017-2028)
2.2 Alzheimer's Disease Diagnostic Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Alzheimer's Disease Diagnostic Market Size by Region (2017-2022)
2.4 Global Alzheimer's Disease Diagnostic Market Size Forecast by Region (2023-2028)
2.5 Global Top Alzheimer's Disease Diagnostic Countries Ranking by Market Size
3 Alzheimer's Disease Diagnostic Competitive by Company
3.1 Global Alzheimer's Disease Diagnostic Revenue by Players
3.1.1 Global Alzheimer's Disease Diagnostic Revenue by Players (2017-2022)
3.1.2 Global Alzheimer's Disease Diagnostic Market Share by Players (2017-2022)
3.2 Global Alzheimer's Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Alzheimer's Disease Diagnostic Revenue
3.4 Global Alzheimer's Disease Diagnostic Market Concentration Ratio
3.4.1 Global Alzheimer's Disease Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alzheimer's Disease Diagnostic Revenue in 2021
3.5 Global Alzheimer's Disease Diagnostic Key Players Head office and Area Served
3.6 Key Players Alzheimer's Disease Diagnostic Product Solution and Service
3.7 Date of Enter into Alzheimer's Disease Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Alzheimer's Disease Diagnostic Breakdown Data by Type
4.1 Global Alzheimer's Disease Diagnostic Historic Revenue by Type (2017-2022)
4.2 Global Alzheimer's Disease Diagnostic Forecasted Revenue by Type (2023-2028)
5 Global Alzheimer's Disease Diagnostic Breakdown Data by Application
5.1 Global Alzheimer's Disease Diagnostic Historic Market Size by Application (2017-2022)
5.2 Global Alzheimer's Disease Diagnostic Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Alzheimer's Disease Diagnostic Revenue by Company (2020-2022)
6.2 North America Alzheimer's Disease Diagnostic Revenue by Type (2017-2028)
6.3 North America Alzheimer's Disease Diagnostic Revenue by Application (2017-2028)
6.4 North America Alzheimer's Disease Diagnostic Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Alzheimer's Disease Diagnostic Revenue by Company (2020-2022)
7.2 Europe Alzheimer's Disease Diagnostic Revenue by Type (2017-2028)
7.3 Europe Alzheimer's Disease Diagnostic Revenue by Application (2017-2028)
7.4 Europe Alzheimer's Disease Diagnostic Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Alzheimer's Disease Diagnostic Revenue by Company (2020-2022)
8.2 Asia Pacific Alzheimer's Disease Diagnostic Revenue by Type (2017-2028)
8.3 Asia Pacific Alzheimer's Disease Diagnostic Revenue by Application (2017-2028)
8.4 Asia Pacific Alzheimer's Disease Diagnostic Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Alzheimer's Disease Diagnostic Revenue by Company (2020-2022)
9.2 Latin America Alzheimer's Disease Diagnostic Revenue by Type (2017-2028)
9.3 Latin America Alzheimer's Disease Diagnostic Revenue by Application (2017-2028)
9.4 Latin America Alzheimer's Disease Diagnostic Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Alzheimer's Disease Diagnostic Revenue by Company (2020-2022)
10.2 Middle East and Africa Alzheimer's Disease Diagnostic Revenue by Type (2017-2028)
10.3 Middle East and Africa Alzheimer's Disease Diagnostic Revenue by Application (2017-2028)
10.4 Middle East and Africa Alzheimer's Disease Diagnostic Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Alzheimer's Disease Diagnostic Products and Services
11.1.4 Eli Lilly Alzheimer's Disease Diagnostic Revenue in Alzheimer's Disease Diagnostic Business (2017-2022)
11.1.5 Eli Lilly Alzheimer's Disease Diagnostic SWOT Analysis
11.1.6 Eli Lilly Recent Developments
11.2 TauRx
11.2.1 TauRx Company Details
11.2.2 TauRx Business Overview
11.2.3 TauRx Alzheimer's Disease Diagnostic Products and Services
11.2.4 TauRx Alzheimer's Disease Diagnostic Revenue in Alzheimer's Disease Diagnostic Business (2017-2022)
11.2.5 TauRx Alzheimer's Disease Diagnostic SWOT Analysis
11.2.6 TauRx Recent Developments
11.3 Alector
11.3.1 Alector Company Details
11.3.2 Alector Business Overview
11.3.3 Alector Alzheimer's Disease Diagnostic Products and Services
11.3.4 Alector Alzheimer's Disease Diagnostic Revenue in Alzheimer's Disease Diagnostic Business (2017-2022)
11.3.5 Alector Alzheimer's Disease Diagnostic SWOT Analysis
11.3.6 Alector Recent Developments
11.4 Accera
11.4.1 Accera Company Details
11.4.2 Accera Business Overview
11.4.3 Accera Alzheimer's Disease Diagnostic Products and Services
11.4.4 Accera Alzheimer's Disease Diagnostic Revenue in Alzheimer's Disease Diagnostic Business (2017-2022)
11.4.5 Accera Alzheimer's Disease Diagnostic SWOT Analysis
11.4.6 Accera Recent Developments
11.5 Treventis
11.5.1 Treventis Company Details
11.5.2 Treventis Business Overview
11.5.3 Treventis Alzheimer's Disease Diagnostic Products and Services
11.5.4 Treventis Alzheimer's Disease Diagnostic Revenue in Alzheimer's Disease Diagnostic Business (2017-2022)
11.5.5 Treventis Alzheimer's Disease Diagnostic SWOT Analysis
11.5.6 Treventis Recent Developments
11.6 Neuro-Bio
11.6.1 Neuro-Bio Company Details
11.6.2 Neuro-Bio Business Overview
11.6.3 Neuro-Bio Alzheimer's Disease Diagnostic Products and Services
11.6.4 Neuro-Bio Alzheimer's Disease Diagnostic Revenue in Alzheimer's Disease Diagnostic Business (2017-2022)
11.6.5 Neuro-Bio Alzheimer's Disease Diagnostic SWOT Analysis
11.6.6 Neuro-Bio Recent Developments
11.7 Cognition Therapeutics
11.7.1 Cognition Therapeutics Company Details
11.7.2 Cognition Therapeutics Business Overview
11.7.3 Cognition Therapeutics Alzheimer's Disease Diagnostic Products and Services
11.7.4 Cognition Therapeutics Alzheimer's Disease Diagnostic Revenue in Alzheimer's Disease Diagnostic Business (2017-2022)
11.7.5 Cognition Therapeutics Alzheimer's Disease Diagnostic SWOT Analysis
11.7.6 Cognition Therapeutics Recent Developments
12 Alzheimer's Disease Diagnostic Market Dynamics
12.1 Alzheimer's Disease Diagnostic Market Trends
12.2 Alzheimer's Disease Diagnostic Market Drivers
12.3 Alzheimer's Disease Diagnostic Market Challenges
12.4 Alzheimer's Disease Diagnostic Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
    Table 1. Global Alzheimer's Disease Diagnostic Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Genetic Testing
    Table 3. Key Players of Neurological Exam
    Table 4. Key Players of Mini-Mental State Exam(MMSE)
    Table 5. Key Players of Brain Imaging
    Table 6. Key Players of Other
    Table 7. Global Alzheimer's Disease Diagnostic Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 8. Global Alzheimer's Disease Diagnostic Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
    Table 9. Global Alzheimer's Disease Diagnostic Revenue by Region (2017-2022) & (US$ Million)
    Table 10. Global Alzheimer's Disease Diagnostic Revenue Market Share by Region (2017-2022)
    Table 11. Global Alzheimer's Disease Diagnostic Revenue by Players (2017-2022) & (US$ Million)
    Table 12. Global Alzheimer's Disease Diagnostic Market Share by Players (2017-2022)
    Table 13. Global Top Alzheimer's Disease Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Diagnostic as of 2021)
    Table 14. Ranking of Global Top Alzheimer's Disease Diagnostic Companies by Revenue (US$ Million) in 2021
    Table 15. Global 5 Largest Players Market Share by Alzheimer's Disease Diagnostic Revenue (CR5 and HHI) & (2017-2022)
    Table 16. Key Players Headquarters and Area Served
    Table 17. Key Players Alzheimer's Disease Diagnostic Product Solution and Service
    Table 18. Date of Key Manufacturers Enter into Alzheimer's Disease Diagnostic Market
    Table 19. Mergers & Acquisitions, Expansion Plans
    Table 20. Global Alzheimer's Disease Diagnostic Market Size by Type (2017-2022) & (US$ Million)
    Table 21. Global Alzheimer's Disease Diagnostic Revenue Market Share by Type (2017-2022)
    Table 22. Global Alzheimer's Disease Diagnostic Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 23. Global Alzheimer's Disease Diagnostic Revenue Market Share by Type (2023-2028)
    Table 24. Global Alzheimer's Disease Diagnostic Market Size by Application (2017-2022) & (US$ Million)
    Table 25. Global Alzheimer's Disease Diagnostic Revenue Market Share by Application (2017-2022)
    Table 26. Global Alzheimer's Disease Diagnostic Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 27. Global Alzheimer's Disease Diagnostic Revenue Market Share by Application (2023-2028)
    Table 28. North America Alzheimer's Disease Diagnostic Revenue by Company (2020-2022) & (US$ Million)
    Table 29. North America Alzheimer's Disease Diagnostic Revenue by Type (2017-2022) & (US$ Million)
    Table 30. North America Alzheimer's Disease Diagnostic Revenue by Type (2023-2028) & (US$ Million)
    Table 31. North America Alzheimer's Disease Diagnostic Revenue by Application (2017-2022) & (US$ Million)
    Table 32. North America Alzheimer's Disease Diagnostic Revenue by Application (2023-2028) & (US$ Million)
    Table 33. North America Alzheimer's Disease Diagnostic Revenue by Country (2017-2022) & (US$ Million)
    Table 34. North America Alzheimer's Disease Diagnostic Revenue by Country (2023-2028) & (US$ Million)
    Table 35. Europe Alzheimer's Disease Diagnostic Revenue by Company (2020-2022) & (US$ Million)
    Table 36. Europe Alzheimer's Disease Diagnostic Revenue by Type (2017-2022) & (US$ Million)
    Table 37. Europe Alzheimer's Disease Diagnostic Revenue by Type (2023-2028) & (US$ Million)
    Table 38. Europe Alzheimer's Disease Diagnostic Revenue by Application (2017-2022) & (US$ Million)
    Table 39. Europe Alzheimer's Disease Diagnostic Revenue by Application (2023-2028) & (US$ Million)
    Table 40. Europe Alzheimer's Disease Diagnostic Revenue by Country (2017-2022) & (US$ Million)
    Table 41. Europe Alzheimer's Disease Diagnostic Revenue by Country (2023-2028) & (US$ Million)
    Table 42. Asia Pacific Alzheimer's Disease Diagnostic Revenue by Company (2020-2022) & (US$ Million)
    Table 43. Asia Pacific Alzheimer's Disease Diagnostic Revenue by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Alzheimer's Disease Diagnostic Revenue by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Alzheimer's Disease Diagnostic Revenue by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Alzheimer's Disease Diagnostic Revenue by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Alzheimer's Disease Diagnostic Revenue by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Alzheimer's Disease Diagnostic Revenue by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Alzheimer's Disease Diagnostic Revenue by Company (2020-2022) & (US$ Million)
    Table 50. Latin America Alzheimer's Disease Diagnostic Revenue by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Alzheimer's Disease Diagnostic Revenue by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Alzheimer's Disease Diagnostic Revenue by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Alzheimer's Disease Diagnostic Revenue by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Alzheimer's Disease Diagnostic Revenue by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Alzheimer's Disease Diagnostic Revenue by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Alzheimer's Disease Diagnostic Revenue by Company (2020-2022) & (US$ Million)
    Table 57. Middle East and Africa Alzheimer's Disease Diagnostic Revenue by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Alzheimer's Disease Diagnostic Revenue by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Alzheimer's Disease Diagnostic Revenue by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Alzheimer's Disease Diagnostic Revenue by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Alzheimer's Disease Diagnostic Revenue by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Alzheimer's Disease Diagnostic Revenue by Country (2023-2028) & (US$ Million)
    Table 63. Eli Lilly Company Details
    Table 64. Eli Lilly Business Overview
    Table 65. Eli Lilly Alzheimer's Disease Diagnostic Product and Services
    Table 66. Eli Lilly Alzheimer's Disease Diagnostic Revenue in Alzheimer's Disease Diagnostic Business (2017-2022) & (US$ Million)
    Table 67. Eli Lilly Alzheimer's Disease Diagnostic SWOT Analysis
    Table 68. Eli Lilly Recent Developments
    Table 69. TauRx Company Details
    Table 70. TauRx Business Overview
    Table 71. TauRx Alzheimer's Disease Diagnostic Product and Services
    Table 72. TauRx Alzheimer's Disease Diagnostic Revenue in Alzheimer's Disease Diagnostic Business (2017-2022) & (US$ Million)
    Table 73. TauRx Alzheimer's Disease Diagnostic SWOT Analysis
    Table 74. TauRx Recent Developments
    Table 75. Alector Company Details
    Table 76. Alector Business Overview
    Table 77. Alector Alzheimer's Disease Diagnostic Product and Services
    Table 78. Alector Alzheimer's Disease Diagnostic Revenue in Alzheimer's Disease Diagnostic Business (2017-2022) & (US$ Million)
    Table 79. Alector Alzheimer's Disease Diagnostic SWOT Analysis
    Table 80. Alector Recent Developments
    Table 81. Accera Company Details
    Table 82. Accera Business Overview
    Table 83. Accera Alzheimer's Disease Diagnostic Product and Services
    Table 84. Accera Alzheimer's Disease Diagnostic Revenue in Alzheimer's Disease Diagnostic Business (2017-2022) & (US$ Million)
    Table 85. Accera Alzheimer's Disease Diagnostic SWOT Analysis
    Table 86. Accera Recent Developments
    Table 87. Treventis Company Details
    Table 88. Treventis Business Overview
    Table 89. Treventis Alzheimer's Disease Diagnostic Product and Services
    Table 90. Treventis Alzheimer's Disease Diagnostic Revenue in Alzheimer's Disease Diagnostic Business (2017-2022) & (US$ Million)
    Table 91. Treventis Alzheimer's Disease Diagnostic SWOT Analysis
    Table 92. Treventis Recent Developments
    Table 93. Neuro-Bio Company Details
    Table 94. Neuro-Bio Business Overview
    Table 95. Neuro-Bio Alzheimer's Disease Diagnostic Product and Services
    Table 96. Neuro-Bio Alzheimer's Disease Diagnostic Revenue in Alzheimer's Disease Diagnostic Business (2017-2022) & (US$ Million)
    Table 97. Neuro-Bio Alzheimer's Disease Diagnostic SWOT Analysis
    Table 98. Neuro-Bio Recent Developments
    Table 99. Cognition Therapeutics Company Details
    Table 100. Cognition Therapeutics Business Overview
    Table 101. Cognition Therapeutics Alzheimer's Disease Diagnostic Product and Services
    Table 102. Cognition Therapeutics Alzheimer's Disease Diagnostic Revenue in Alzheimer's Disease Diagnostic Business (2017-2022) & (US$ Million)
    Table 103. Cognition Therapeutics Alzheimer's Disease Diagnostic SWOT Analysis
    Table 104. Cognition Therapeutics Recent Developments
    Table 105. Alzheimer's Disease Diagnostic Market Trends
    Table 106. Alzheimer's Disease Diagnostic Market Drivers
    Table 107. Alzheimer's Disease Diagnostic Market Challenges
    Table 108. Alzheimer's Disease Diagnostic Market Restraints
    Table 109. Research Programs/Design for This Report
    Table 110. Key Data Information from Secondary Sources
    Table 111. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Alzheimer's Disease Diagnostic Sales Market Share by Type: 2021 VS 2028
    Figure 2. Genetic Testing Features
    Figure 3. Neurological Exam Features
    Figure 4. Mini-Mental State Exam(MMSE) Features
    Figure 5. Brain Imaging Features
    Figure 6. Other Features
    Figure 7. Global Alzheimer's Disease Diagnostic Sales Market Share by Application: 2021 VS 2028
    Figure 8. Clinics Case Studies
    Figure 9. Hospitals Case Studies
    Figure 10. Diagnostic Centers Case Studies
    Figure 11. Other Case Studies
    Figure 12. Alzheimer's Disease Diagnostic Report Years Considered
    Figure 13. Global Alzheimer's Disease Diagnostic Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Alzheimer's Disease Diagnostic Market Size 2017-2028 (US$ Million)
    Figure 15. Global Alzheimer's Disease Diagnostic Market Size Market Share by Region: 2021 VS 2028
    Figure 16. Global Alzheimer's Disease Diagnostic Revenue Market Share by Region in 2017 VS 2022
    Figure 17. Global Top 10 Alzheimer's Disease Diagnostic Countries Ranking by Market Size (US$ Million) in 2021
    Figure 18. Global Alzheimer's Disease Diagnostic Market Share by Players in 2021
    Figure 19. Global Top Alzheimer's Disease Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Diagnostic as of 2021)
    Figure 20. The Top 10 and 5 Players Market Share by Alzheimer's Disease Diagnostic Revenue in 2021
    Figure 21. North America Alzheimer's Disease Diagnostic Revenue Market Share by Company in 2021
    Figure 22. North America Alzheimer's Disease Diagnostic Revenue Market Share by Type (2017-2028)
    Figure 23. North America Alzheimer's Disease Diagnostic Revenue Market Share by Application (2017-2028)
    Figure 24. North America Alzheimer's Disease Diagnostic Revenue Share by Country (2017-2028)
    Figure 25. U.S. Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
    Figure 26. Canada Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
    Figure 27. Europe Alzheimer's Disease Diagnostic Revenue Market Share by Company in 2021
    Figure 28. Europe Alzheimer's Disease Diagnostic Revenue Market Share by Type (2017-2028)
    Figure 29. Europe Alzheimer's Disease Diagnostic Revenue Market Share by Application (2017-2028)
    Figure 30. Europe Alzheimer's Disease Diagnostic Revenue Share by Country (2017-2028)
    Figure 31. Germany Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
    Figure 32. France Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
    Figure 33. U.K. Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
    Figure 34. Italy Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
    Figure 35. Russia Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
    Figure 36. Asia Pacific Alzheimer's Disease Diagnostic Revenue Market Share by Company in 2021
    Figure 37. Asia Pacific Alzheimer's Disease Diagnostic Revenue Market Share by Type (2017-2028)
    Figure 38. Asia Pacific Alzheimer's Disease Diagnostic Revenue Market Share by Application (2017-2028)
    Figure 39. Asia Pacific Alzheimer's Disease Diagnostic Revenue Share by Region (2017-2028)
    Figure 40. China Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
    Figure 41. Japan Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
    Figure 42. South Korea Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
    Figure 43. India Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
    Figure 44. Australia Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
    Figure 45. Taiwan Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
    Figure 46. Indonesia Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
    Figure 47. Thailand Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
    Figure 48. Malaysia Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
    Figure 49. Philippines Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
    Figure 50. Vietnam Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
    Figure 51. Latin America Alzheimer's Disease Diagnostic Revenue Market Share by Company in 2021
    Figure 52. Latin America Alzheimer's Disease Diagnostic Revenue Market Share by Type (2017-2028)
    Figure 53. Latin America Alzheimer's Disease Diagnostic Revenue Market Share by Application (2017-2028)
    Figure 54. Latin America Alzheimer's Disease Diagnostic Revenue Share by Country (2017-2028)
    Figure 55. Mexico Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
    Figure 56. Brazil Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
    Figure 57. Argentina Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
    Figure 58. Middle East and Africa Alzheimer's Disease Diagnostic Revenue Market Share by Company in 2021
    Figure 59. Middle East and Africa Alzheimer's Disease Diagnostic Revenue Market Share by Type (2017-2028)
    Figure 60. Middle East and Africa Alzheimer's Disease Diagnostic Revenue Market Share by Application (2017-2028)
    Figure 61. Middle East and Africa Alzheimer's Disease Diagnostic Revenue Share by Country (2017-2028)
    Figure 62. Turkey Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
    Figure 63. Saudi Arabia Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
    Figure 64. U.A.E Alzheimer's Disease Diagnostic Revenue (2017-2028) & (US$ Million)
    Figure 65. Eli Lilly Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2017-2022)
    Figure 66. TauRx Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2017-2022)
    Figure 67. Alector Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2017-2022)
    Figure 68. Accera Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2017-2022)
    Figure 69. Treventis Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2017-2022)
    Figure 70. Neuro-Bio Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2017-2022)
    Figure 71. Cognition Therapeutics Revenue Growth Rate in Alzheimer's Disease Diagnostic Business (2017-2022)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5600

This license allows only one user to access the PDF.
Electronic (PDF)

$8400

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11200

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS